| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | |
|---|---|---|
| Revenue | ||
| Cost of revenue | ||
| Operating income | ||
| Operating margin | ||
| Net income | ||
| Net profit margin | ||
| Cash on hand | ||
| Change in cash | ||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 3.30 mm | 3.30 mm | 3.30 mm | 3.30 mm | 3.30 mm | 3.30 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 720.08 k | 810.57 k | 695.99 k | 1.21 mm |
| Cash used (since last report) | n/a | n/a | 3.88 mm | 4.36 mm | 3.75 mm | 6.49 mm |
| Cash remaining | n/a | n/a | -576.87 k | -1.06 mm | -447.12 k | -3.19 mm |
| Runway (months of cash) | n/a | n/a | -0.8 | -1.3 | -0.6 | -2.6 |
| 13F holders | Current |
|---|---|
| Total holders | 9 |
| Opened positions | 7 |
| Closed positions | 9 |
| Increased positions | 0 |
| Reduced positions | 1 |
| 13F shares | Current |
|---|---|
| Total value | 32.88 mm |
| Total shares | 2.00 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Knight Therapeutics | 1.11 mm | $0.00 |
| Sabby Management | 271.13 k | $15.54 mm |
| Walleye Capital | 222.91 k | $12.77 mm |
| KHTRF Knight Therapeutics | 169.49 k | $139.00 k |
| Clear Street | 146.52 k | $8.00 k |
| Torno Capital | 47.17 k | $2.70 mm |
| Warberg Asset Management | 29.52 k | $1.51 mm |
| Federation des caisses Desjardins du Quebec | 5.00 k | $210.00 k |
| UBS UBS | 80.00 | $3.00 k |
| Proequities | 0.00 | $0.00 |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 17 Jan 25 | Tyrone Miller | Common Stock | Grant | Acquire A | No | No | 0 | 11,626 | 0.00 | 26,370 |
| 17 Jan 25 | Geoffrey S Dow | Common Stock | Grant | Acquire A | No | No | 0 | 14,394 | 0.00 | 108,974 |
| 2 Jan 25 | Tyrone Miller | Stock Option Common Stock | Grant | Acquire A | No | No | 1.31 | 75,000 | 98.25 k | 75,000 |
| 2 Jan 25 | Geoffrey S Dow | Stock Option Common Stock | Grant | Acquire A | No | No | 1.31 | 525,000 | 687.75 k | 525,000 |
| 16 Dec 24 | Cheryl Xu | Common Stock | Buy | Acquire P | No | No | 1.45 | 2,000 | 2.90 k | 54,078 |
| 13 Dec 24 | Cheryl Xu | Common Stock | Buy | Acquire P | No | No | 1.52 | 1,500 | 2.28 k | 52,078 |
| 13 Dec 24 | Cheryl Xu | Common Stock | Buy | Acquire P | No | No | 1.55 | 1,500 | 2.33 k | 50,578 |
| 13 Dec 24 | Cheryl Xu | Common Stock | Buy | Acquire P | No | No | 1.58 | 1,500 | 2.37 k | 49,078 |
| 13 Dec 24 | Cheryl Xu | Common Stock | Buy | Acquire P | No | No | 1.6 | 1,500 | 2.40 k | 47,578 |
| 12 Dec 24 | Cheryl Xu | Common Stock | Buy | Acquire P | No | No | 1.8 | 2,500 | 4.50 k | 46,078 |
